DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Etodolac (Etodolac) - Neoplasm Progression - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Neoplasm Progression (4)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Etodolac where reactions include neoplasm progression. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Etodolac side effects in male

Reported by a physician from Japan on 2012-08-23

Patient: male, weighing 50.0 kg (110.0 pounds)

Reactions: Renal Impairment, C-Reactive Protein Increased, Neoplasm Malignant, Neoplasm Progression, Pyrexia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: 5 mg, daily
    Administration route: Oral
    Start date: 2012-01-06
    End date: 2012-01-09

Afinitor
    Dosage: 5 mg, daily
    Administration route: Oral
    Start date: 2011-12-14
    End date: 2011-12-29

Afinitor
    Dosage: 10 mg, daily
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2011-06-20
    End date: 2011-10-03

Etodolac
    Dosage: 400 mg, daily
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma

Prednisolone
    Dosage: 5 mg
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2011-06-21
    End date: 2011-09-01

Zometa
    Dosage: unk ukn, unk
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2011-06-27

Other drugs received by patient: Allopurinol; Benidipine Hydrochloride; Vitamin B12; Limaprost Alfadex; Lansoprazole; Limaprost Alfadex; Flivas; Acetaminophen



Possible Etodolac side effects in male

Reported by a physician from Japan on 2012-07-02

Patient: male, weighing 50.0 kg (110.0 pounds)

Reactions: Death, Renal Impairment, Neoplasm Malignant, C-Reactive Protein Increased, Neoplasm Progression, Pyrexia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: 10 mg, daily
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2011-06-20
    End date: 2011-10-03

Afinitor
    Dosage: 5 mg, daily
    Administration route: Oral
    Start date: 2011-12-14
    End date: 2011-12-29

Afinitor
    Dosage: 5 mg, daily
    Administration route: Oral
    Start date: 2012-01-06
    End date: 2012-01-09

Etodolac
    Dosage: 400 mg, daily
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma

Prednisolone Sodium Succinate INJ
    Dosage: 5 mg
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2011-06-21
    End date: 2011-09-01

Zometa
    Dosage: unk ukn, unk
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2011-06-27

Other drugs received by patient: Lansoprazole; Limaprost Alfadex; Flivastatin Sodium; Allopurinol; Vitamin B12; Limaprost Alfadex; Benidipine Hydrochloride; Acetaminophen



Possible Etodolac side effects in 77 year old male

Reported by a pharmacist from Japan on 2012-04-05

Patient: 77 year old male

Reactions: Neoplasm Malignant, Drug Interaction, Neoplasm Progression, Asthenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Etodolac

Other drugs received by patient possibly interacting with the suspect drug:
Lyrica
    Dosage: 150mg, daily
    Administration route: Oral
    Indication: Cancer Pain
    Start date: 2011-02-15
    End date: 2011-02-28

Morphine Sulfate
    Dosage: 30mg, daily
    Administration route: Oral
    Indication: Cancer Pain
    Start date: 2010-01-11



Possible Etodolac side effects in male

Reported by a physician from Japan on 2012-03-15

Patient: male, weighing 50.0 kg (110.0 pounds)

Reactions: Renal Impairment, Neoplasm Malignant, C-Reactive Protein Increased, Neoplasm Progression, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: 10 mg, daily
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2011-06-20
    End date: 2011-10-03

Afinitor
    Dosage: 5 mg, daily
    Administration route: Oral
    Start date: 2011-12-14
    End date: 2011-12-29

Afinitor
    Dosage: 5 mg, daily
    Administration route: Oral
    Start date: 2012-01-06
    End date: 2012-01-09

Etodolac
    Dosage: 400 mg, daily
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma

Prednisolone
    Dosage: 5 mg
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2011-06-21
    End date: 2011-09-01

Zometa
    Dosage: unk ukn, unk
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2011-06-27

Other drugs received by patient: Allopurinol; Benidipine Hydrochloride; Acetaminophen; Lansoprazole; Limaprost Alfadex; Methycobal; Flivas; Limaprost Alfadex

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017